249 related articles for article (PubMed ID: 15195244)
1. Analysis of immune activation and clinical events in acute infectious mononucleosis.
Williams H; Macsween K; McAulay K; Higgins C; Harrison N; Swerdlow A; Britton K; Crawford D
J Infect Dis; 2004 Jul; 190(1):63-71. PubMed ID: 15195244
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
[TBL] [Abstract][Full Text] [Related]
3. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
4. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
[TBL] [Abstract][Full Text] [Related]
8. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
[TBL] [Abstract][Full Text] [Related]
9. High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease.
Enose-Akahata Y; Matsuura E; Oh U; Jacobson S
PLoS Pathog; 2009 Dec; 5(12):e1000682. PubMed ID: 19997502
[TBL] [Abstract][Full Text] [Related]
10. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.
Wang N; Morra M; Wu C; Gullo C; Howie D; Coyle T; Engel P; Terhorst C
Immunogenetics; 2001 Jul; 53(5):382-94. PubMed ID: 11486275
[TBL] [Abstract][Full Text] [Related]
11. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
12. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
[TBL] [Abstract][Full Text] [Related]
13. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.
Henning G; Kraft MS; Derfuss T; Pirzer R; de Saint-Basile G; Aversa G; Fleckenstein B; Meinl E
Eur J Immunol; 2001 Sep; 31(9):2741-50. PubMed ID: 11536173
[TBL] [Abstract][Full Text] [Related]
14. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice.
Chen G; Tai AK; Lin M; Chang F; Terhorst C; Huber BT
J Immunol; 2005 Aug; 175(4):2212-8. PubMed ID: 16081788
[TBL] [Abstract][Full Text] [Related]
15. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
Graham DB; Bell MP; McCausland MM; Huntoon CJ; van Deursen J; Faubion WA; Crotty S; McKean DJ
J Immunol; 2006 Jan; 176(1):291-300. PubMed ID: 16365421
[TBL] [Abstract][Full Text] [Related]
16. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production.
Aversa G; Chang CC; Carballido JM; Cocks BG; de Vries JE
J Immunol; 1997 May; 158(9):4036-44. PubMed ID: 9126961
[TBL] [Abstract][Full Text] [Related]
17. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells.
Castro AG; Hauser TM; Cocks BG; Abrams J; Zurawski S; Churakova T; Zonin F; Robinson D; Tangye SG; Aversa G; Nichols KE; de Vries JE; Lanier LL; O'Garra A
J Immunol; 1999 Dec; 163(11):5860-70. PubMed ID: 10570270
[TBL] [Abstract][Full Text] [Related]
18. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis.
Pasquinelli V; Quiroga MF; Martínez GJ; Zorrilla LC; Musella RM; Bracco MM; Belmonte L; Malbrán A; Fainboim L; Sieling PA; García VE
J Immunol; 2004 Jan; 172(2):1177-85. PubMed ID: 14707094
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP.
Mehrle S; Schmidt J; Büchler MW; Watzl C; Märten A
Mol Immunol; 2008 Feb; 45(3):796-804. PubMed ID: 17692919
[TBL] [Abstract][Full Text] [Related]
20. Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection.
Quiroga MF; Martínez GJ; Pasquinelli V; Costas MA; Bracco MM; Malbrán A; Olivares LM; Sieling PA; García VE
J Immunol; 2004 Sep; 173(6):4120-9. PubMed ID: 15356162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
